SCHEMBL503183

SCHEMBL503183

Fc1cc(-c2ccc(-c3ccccc3)cc2F)ccc1I

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 4/20 0.44
ALOX5AP P20292 3/20 0.44
PTPRC P08575 1/20 0.40
PTPN1 P18031 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
APAF1 O14727 1/20 0.39
NPC1 O15118 1/20 0.39
THRB P10828 1/20 0.39
XBP1 P17861 1/20 0.39
PTBP1 P26599 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
GALK1 P51570 1/20 0.39
BLM P54132 1/20 0.39
SMAD3 P84022 1/20 0.39
ATM Q13315 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23349943 0.90 HSD17B1 (0.42) MEN1KMT2ALMNAMAPTHTT
SCHEMBL19308531 0.86 FEN1 (0.50) FEN1ALOX5APPTPRCPTPN1MEN1
SCHEMBL2140807 0.84 PTGS1 (0.49) FEN1ALOX5APMEN1KMT2ALMNA
SCHEMBL15077185 0.84 PTGS1 (0.49) FEN1ALOX5APMEN1KMT2ALMNA
SCHEMBL28566500 0.84 PTGS1 (0.49) FEN1ALOX5APMEN1KMT2ALMNA
SCHEMBL6065273 0.82 PTPRC (0.52) FEN1ALOX5APPTPRCPTPN1MAPT
SCHEMBL19400433 0.82 MEN1 (0.50) FEN1ALOX5APPTPRCPTPN1MEN1
SCHEMBL20663902 0.82 MEN1 (0.48) FEN1ALOX5APMEN1KMT2ALMNA
SCHEMBL24017170 0.81 TTR (0.47) FEN1ALOX5APMEN1KMT2ALMNA
SCHEMBL13614541 0.80 ALDH1A1 (0.35) FEN1ALOX5APESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8372975-B2 Liquid crystal compound having difluoropropenyleneoxy bonding group JNC CORPORATION (JP) 2013-02-12 US disclosed
US-20120029194-A1 LIQUID CRYSTAL COMPOUND HAVING DIFLUOROPROPENYLENEOXY BONDING GROUP CHISSO PETROCHEMICAL CORPORATION (JP) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029194-A1 LIQUID CRYSTAL COMPOUND HAVING DIFLUOROPROPENYLENEOXY BONDING GROUP LEF1, EIF4A3, TCF4 FEN1 1314/4885ALOX5AP 3260/4885PTPRC 3407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.